TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Genetic Signatures Ltd. ( (AU:GSS) ) has shared an announcement.
Genetic Signatures Ltd has announced the details of its 2025 Annual General Meeting, scheduled for November 17, 2025. The meeting will cover the consideration of financial reports, allow shareholder engagement with the company’s management and auditors, and include resolutions for the re-election of directors. This AGM is an opportunity for stakeholders to engage with the company’s strategic direction and governance.
The most recent analyst rating on (AU:GSS) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Genetic Signatures Ltd. stock, see the AU:GSS Stock Forecast page.
More about Genetic Signatures Ltd.
Genetic Signatures Ltd is a specialist molecular diagnostics company focused on developing and commercializing its proprietary platform technology, 3base®. The company designs and manufactures real-time PCR-based products under the EasyScreen™ brand for detecting infectious diseases. Its target markets include major hospitals and pathology laboratories, with a focus on screening for various infectious pathogens, including antibiotic-resistant bacteria and sexually transmitted infections.
Average Trading Volume: 149,750
Technical Sentiment Signal: Sell
Current Market Cap: A$48.83M
See more insights into GSS stock on TipRanks’ Stock Analysis page.